An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Charleston Hematology Oncology, Charleston

Northwest Georgia Oncology Centers PC - Marietta, Marietta

Peachtree Hematology & Oncology Consultants, Pc, Atlanta

Clearview Cancer Institute, Huntsville

Mark H. Zangmeister Center, Columbus

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

Center for Cancer Care, Goshen

Horizon Oncology Research, Inc., Lafayette

Vince Lombardi Cancer Clinic Pharmacy, Green Bay

Joliet Oncology Hematology Associates, Ltd., Joliet

Illinois Cancer Care, P.C. - Galesburg, Galesburg

Illinois Cancer Care, Peoria

Highlands Oncology Group, Rogers

Kootenai Cancer Center, Coeur d'Alene

San Juan Oncology Associates, Farmington

University of California San Diego, La Jolla

Bay Area Cancer Research Group, LLC, Pleasant Hill

Northwest Medical Specialties, Tacoma

Cancer Center of Central Conn., Southington